MTHFR and acute lymphoblastic leukemia: A previous study reported that the T allele of MTHFR rs1801133 was associated with an increased risk of relapse events but not associated with MTX concentrations nor adverse events and that rs1801131 was not associated with altered risks of relapse nor toxicity in 520 pediatric ALL patients by the Children's Oncology Group [13].